Confluent Diode Laser Coagulation: The Gold Standard of Therapy for Retinopathy of Prematurity

Prepiaková, Z; Tomčíková, Dana; Kostolná, B; Gerinec, A

doi:10.3928/01913913-20141230-07

Cited by 5 publications

(15 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[14][15][16][21][22][23] ). When comparing the methods of single spots and near confluent photocoagulation, the method of dense laser photocoagulation seems to be more effective and safer [23][24][25] . The complications of the CALCR procedure do not vary in principle from the complications that are described in standard methods of treatment with laser and cryocoagulation under the visual control of an indirect ophthalmoscope [12][13][14][15][16]19,20,22 .…”

Section: Discussionmentioning

confidence: 99%

A new modified technique for the treatment of high-risk prethreshold ROP under the direct visual control of RetCam 3

Timkovič¹,

Němčanský²,

Cholevík³

et al. 2015

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

A new modified technique for the treatment of high-risk prethreshold ROP under the direct visual control of RetCam 3

Timkovič¹,

Němčanský²,

Cholevík³

et al. 2015

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub

View full text Add to dashboard Cite

“…Nine 10,25-32 included documents were obtained through systematic search, one 33 came from bibliographies of published papers, ten [34][35][36][37][38][39][40][41][42][43] were found using Google and three [44][45][46] were obtained from one of the authors. Publication dates ranged from 2005 to 2020.…”

Section: Overview Of Publicationsmentioning

confidence: 99%

“…In four countries the authors based their recommendations on previously published ROP guidelines 36,41,43,46 (1 LMIC, 1 UMIC, 2 HICs). A systematic review was carried out during the development of four guidelines 10,25,32,36 (1 LMIC, 2 UMICs, 1 HIC), and was possibly used in developing the Philippine (PAO) guidelines (LMIC).…”

Section: Quality Of the Evidencementioning

confidence: 99%

Systematic review of the guidelines for retinopathy of prematurity

Kościółek

Kisielewska

Ćwiklik-Wierzbowska

et al. 2022

European Journal of Ophthalmology

View full text Add to dashboard Cite

As the characteristics of preterm infants with retinopathy of prematurity (ROP) vary, depending on the quality of neonatal care they received, universal screening criteria for ROP are not possible. The purpose of this study was to compare ROP guidelines for those planning to develop guidelines, particularly in resource-poor settings. A systematic review was undertaken of PubMed, Embase and guidelines registers to identify national or international policy statements or guidelines in English, issued or operational in 2010–2021. Bibliographies of two publications were also reviewed. The searches identified 633, 1081 and 317 records, respectively, and 157 records were retrieved from other sources. 23 publications were included in the analysis. Most included documents defined cut-offs for screening as <32 weeks gestational age (GA) or ≤1500g birth weight (BW). The highest values were in the Philippines (<35 weeks GA; <2000g) and India (≤34 weeks GA; <2000g). The lowest were in high-income countries, i.e. the United States of America (≤32 weeks for GA) and New Zealand (<1250g for BW). Most guidelines included additional risk factors to consider. The most frequent indication for when screening should start was a combination of GA and chronological age. All but one document defined when screening could stop. There was general consensus on the indications, timing and methods of treatment. Indications for anti-VEGF therapy varied between countries. Guidelines were identified for a limited number of countries with none from low-income settings. Variation in the indications for screening reflects the varying exposure to risk factors in different settings.

show abstract

“…Laser photocoagulation is the standard of treatment choice in an attempt to slow down or reverse the growth of abnormal blood vessels and scar tissue formation despite problems such as visual field loss and development of myopia. 4 , 5 Recent research studies have shown that although laser treatment produces excellent results, 10% of the patients still may have unfavorable results. 6 …”

Section: Introductionmentioning

confidence: 99%

Intravitreal bevacizumab as rescue therapy following treatment failure with laser photocoagulation in retinopathy of prematurity

Kara

Hekimoğlu

Petriçli

et al. 2018

Journal of Current Ophthalmology

View full text Add to dashboard Cite

PurposeTo evaluate the efficacy of intravitreal bevacizumab (IVB) in case of treatment failure with laser photocoagulation in retinopathy of prematurity (ROP).MethodsA retrospective review of infants treated with IVB injection due to treatment failure with laser photocoagulation was performed. The anatomical results and complications were evaluated after treatment.Results9 eyes of 6 premature infants with a mean gestational age of 26.8 ± 3.0 weeks (range, 23–32 w) and mean birth weight of 958 ± 319 g (range, 600–1400 g) were identified. Six of the eyes had zone 1 disease, and all of these eyes were classified as aggressive posterior ROP (APROP). Three of the eyes had zone 2 disease, and one of these eyes was classified as APROP, and the other two eyes were classified as high-risk pre-threshold disease. All of the eyes showed regression of the disease except one patient, both eyes of whom progressed to stage 4A. None of the patients developed ocular and systemic complications at the end of the six-month follow-up period.ConclusionIVB could be an option in patients with ROP in whom laser photocoagulation failed.

show abstract

Confluent Diode Laser Coagulation: The Gold Standard of Therapy for Retinopathy of Prematurity

Abstract: The DLC method was significantly more effective than single-spot DLC in the treatment of retinopathy of prematurity.

Cited by 5 publications

References 25 publications

A new modified technique for the treatment of high-risk prethreshold ROP under the direct visual control of RetCam 3

A new modified technique for the treatment of high-risk prethreshold ROP under the direct visual control of RetCam 3

Systematic review of the guidelines for retinopathy of prematurity

Intravitreal bevacizumab as rescue therapy following treatment failure with laser photocoagulation in retinopathy of prematurity

Contact Info

Product

Resources

About